CSIMarket



Worst Performing Stocks In Medical Laboratories Industry During This Month Of July



 1 Day   Week  Current Month of July  30 Days 
Current Quarter Q3 of 2024  90 Days    Ytd    12 Months 
 

Shares are up by 6.96% on average, in Medical Laboratories Industry during this month of July.

Here are the Worst performing stocks in Medical Laboratories Industry.




HALB

$0.0076

$-0.0011 -12.64%
This Month of July


HALB

$0.0076

$-0.0011 -12.64%



Halberd Corporation

Halberd Corporation shares went down -12.64% during this month of July.


Halberd Corporation*s business model focuses on providing a range of products or services to meet specific industries* needs, with a targeted approach and a customer-centric approach.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 3.898 mill. $ 0.001 mill. $ -0.297 mill. 513 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 3.898 mill.


$ 0.001 mill.


$ -0.297 mill.

Employees Shares Outstanding P/E

-


513 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



FOXO

$0.25

$-0.0330 -11.66%
This Month of July


FOXO

$0.25

$-0.0330 -11.66%



Foxo Technologies Inc

Foxo Technologies Inc shares dropped -11.66% during this month of July.





Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 1.220 mill. $ 0.546 mill. $ -109.518 mill. 5 mill. - Y/Y -28.57 %
Market Cap. Revenues TTM Net Income TTM

$ 1.220 mill.


$ 0.546 mill.


$ -109.518 mill.

Employees Shares Outstanding P/E

-


5 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -28.57 %


MRQ Y/Y - %



CSTL

$18.85

$-2.3400 -11.04%
This Month of July


CSTL

$18.85

$-2.3400 -11.04%



Castle Biosciences Inc

Castle Biosciences Inc stock dropped -11.04% during this month of July.


Castle Biosciences Inc is a biotechnology company that specializes in the development and commercialization of diagnostic tests for specialized cancers. Their business model revolves around leveraging molecular diagnostic technologies to provide physicians with personalized, actionable information when making treatment decisions for patients with difficult-to-diagnose or higher-risk cancers. By offering these tests, Castle Biosciences aims to improve patient outcomes and contribute to the advancement of precision medicine.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 518.092 mill. $ 250.725 mill. $ -0.132 mill. 27 mill. - Y/Y 73.59 %
Market Cap. Revenues TTM Net Income TTM

$ 518.092 mill.


$ 250.725 mill.


$ -0.132 mill.

Employees Shares Outstanding P/E

200


27 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 73.59 %


MRQ Y/Y - %



ISPC

$0.2846

$-0.0185 -6.10%
This Month of July


ISPC

$0.2846

$-0.0185 -6.10%



Ispecimen inc

Ispecimen Inc stock declined -6.10% during this month of July.


iSpecimen Inc*s business model revolves around connecting researchers with the biospecimens they need for their scientific and medical studies. They serve as an intermediary platform that links healthcare organizations and biobanks to the research community, providing a streamlined process for sourcing human biosamples and associated data.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 2.599 mill. $ 9.268 mill. $ -11.570 mill. 9 mill. - Y/Y -22.38 %
Market Cap. Revenues TTM Net Income TTM

$ 2.599 mill.


$ 9.268 mill.


$ -11.570 mill.

Employees Shares Outstanding P/E

-


9 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -22.38 %


MRQ Y/Y - %



LUNA

$2.91

$-0.0400 -1.36%
This Month of July


LUNA

$2.91

$-0.0400 -1.36%



Luna Innovations Inc

Luna Innovations Inc shares declined -1.36% during this month of July.


Luna Innovations Inc*s business model involves providing advanced technology solutions and services to various industries.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 102.486 mill. $ 113.692 mill. $ -1.781 mill. 35 mill. - Y/Y 17.07 %
Market Cap. Revenues TTM Net Income TTM

$ 102.486 mill.


$ 113.692 mill.


$ -1.781 mill.

Employees Shares Outstanding P/E

236


35 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 17.07 %


MRQ Y/Y - %



PMD

$2.32

$-0.0300 -1.28%
This Month of July


PMD

$2.32

$-0.0300 -1.28%



Psychemedics Corporation

Psychemedics Corporation stock declined -1.28% during this month of July.


Psychemedics Corp*s business model is focused on providing hair drug testing services to corporate clients, law enforcement agencies, and individuals. They collect hair samples, conduct extensive laboratory analysis, and deliver accurate and confidential drug test results to their customers.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 13.470 mill. $ 20.676 mill. $ -4.458 mill. 6 mill. - Y/Y -12.58 %
Market Cap. Revenues TTM Net Income TTM

$ 13.470 mill.


$ 20.676 mill.


$ -4.458 mill.

Employees Shares Outstanding P/E

-


6 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -12.58 %


MRQ Y/Y - %



CHEK

$2.03

$-0.0100 -0.49%
This Month of July


CHEK

$2.03

$-0.0100 -0.49%



Check cap Ltd

Check Cap Ltd stock went down -0.49% during this month of July.


Check Cap Ltd is a medical technology company that develops and commercializes an ingestible imaging capsule that allows for the detection and monitoring of colorectal polyps. Their business model revolves around manufacturing and selling this capsule device while also providing associated services and support to healthcare professionals and patients.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 11.873 mill. $ - mill. $ 17.568 mill. 6 mill. 0.68 Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 11.873 mill.


$ - mill.


$ 17.568 mill.

Employees Shares Outstanding P/E

-


6 mill.


0.68

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y -8.06 %



ACON

$0.2924

$0.0014 0.48%
This Month of July


ACON

$0.2924

$0.0014 0.48%



Aclarion Inc

Aclarion Inc stock went up 0.48% during this month of July.


Aclarion Inc is a technology company that operates on a software-as-a-service (SaaS) business model. They provide their customers with cloud-based solutions, enabling them to streamline and automate their business processes efficiently. Aclarion offers a range of customizable software solutions, including data management, project management, and collaboration tools, tailored to meet the specific needs of their clients.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 1.591 mill. $ 0.060 mill. $ -6.127 mill. 5 mill. - Y/Y -60.29 %
Market Cap. Revenues TTM Net Income TTM

$ 1.591 mill.


$ 0.060 mill.


$ -6.127 mill.

Employees Shares Outstanding P/E

-


5 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -60.29 %


MRQ Y/Y - %



AMS

$3.25

$0.0450 1.40%
This Month of July


AMS

$3.25

$0.0450 1.40%



American Shared Hospital Services

American Shared Hospital Services shares went up 1.40% during this month of July.


American Shared Hospital Services (ASHS) operates a unique business model by providing state-of-the-art medical equipment on a shared basis to hospitals and medical centers across the United States. They establish partnerships with healthcare providers, offering the latest technology for radiation therapy, radiosurgery, and nuclear medicine without the need for significant capital investments. By leveraging their expertise and established relationships in the healthcare industry, ASHS delivers cost-effective solutions that benefit both patients and healthcare facilities alike.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 21.372 mill. $ 20.562 mill. $ 0.230 mill. 7 mill. 38.72 Y/Y 4.43 %
Market Cap. Revenues TTM Net Income TTM

$ 21.372 mill.


$ 20.562 mill.


$ 0.230 mill.

Employees Shares Outstanding P/E

-


7 mill.


38.72

Revenue Growth Income Growth

MRQ Y/Y 4.43 %


MRQ Y/Y -35.00 %



LH

$207.49

$4.3600 2.15%
This Month of July


LH

$207.49

$4.3600 2.15%



Laboratory Corporation Of America Holdings

Laboratory Corporation Of America Holdings stock went up 2.15% during this month of July.


Laboratory Corporation Of America Holdings operates as a leading healthcare diagnostics company. They offer a range of clinical laboratory tests and services to healthcare providers, pharmaceutical companies, and government agencies. Their business model focuses on providing accurate and timely test results, enabling healthcare professionals to diagnose, treat, and monitor patients effectively.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 17,586.513 mill. $ 11,560.300 mill. $ 434.200 mill. 85 mill. 41.91 Y/Y -15.92 %
Market Cap. Revenues TTM Net Income TTM

$ 17,586.513 mill.


$ 11,560.300 mill.


$ 434.200 mill.

Employees Shares Outstanding P/E

75,500


85 mill.


41.91

Revenue Growth Income Growth

MRQ Y/Y -15.92 %


MRQ Y/Y 7.03 %



NRC

$23.49

$0.5900 2.58%
This Month of July


NRC

$23.49

$0.5900 2.58%



National Research Corporation

National Research Corporation shares improved 2.58% during this month of July.


National Research Corporation (NRC) operates as a healthcare research and performance measurement firm, providing insights and data-driven solutions. They collect, analyze, and interpret patient and healthcare provider feedback to assist organizations in improving their overall quality of care. NRC*s business model focuses on selling research products, licensing data services, and providing consulting solutions to healthcare organizations seeking to enhance patient experiences and outcomes.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 562.891 mill. $ 147.420 mill. $ 30.366 mill. 24 mill. 18.91 Y/Y -3.18 %
Market Cap. Revenues TTM Net Income TTM

$ 562.891 mill.


$ 147.420 mill.


$ 30.366 mill.

Employees Shares Outstanding P/E

-


24 mill.


18.91

Revenue Growth Income Growth

MRQ Y/Y -3.18 %


MRQ Y/Y -8.69 %



PHG

$26

$0.9200 3.67%
This Month of July


PHG

$26

$0.9200 3.67%



Koninklijke Philips Nv

Koninklijke Philips Nv stock went up 3.67% during this month of July.


Koninklijke Philips Nv operates as a diversified technology company, focusing on areas such as healthcare, consumer lifestyle, and lighting. The company provides a wide range of products and solutions, including medical imaging equipment, home appliances, personal care products, and lighting solutions. Philips Nv*s business model involves innovation-driven research and development, strategic partnerships, and a global distribution network to deliver its products and services to customers worldwide.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 23,756.863 mill. $ 20,349.280 mill. $ -518.560 mill. 914 mill. - Y/Y 1.92 %
Market Cap. Revenues TTM Net Income TTM

$ 23,756.863 mill.


$ 20,349.280 mill.


$ -518.560 mill.

Employees Shares Outstanding P/E

82,000


914 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 1.92 %


MRQ Y/Y - %



HOLX

$77.34

$3.2400 4.37%
This Month of July


HOLX

$77.34

$3.2400 4.37%



Hologic Inc

Hologic Inc stock increased 4.37% during this month of July.


Hologic Inc*s business model revolves around the development, manufacturing, and commercialization of medical technology and diagnostic products, primarily focused on women*s healthcare. They aim to provide innovative solutions for various medical specialties, including breast and skeletal health, gynecological health, and surgical products.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 18,373.045 mill. $ 4,046.300 mill. $ 621.900 mill. 238 mill. 29.52 Y/Y -0.85 %
Market Cap. Revenues TTM Net Income TTM

$ 18,373.045 mill.


$ 4,046.300 mill.


$ 621.900 mill.

Employees Shares Outstanding P/E

6,944


238 mill.


29.52

Revenue Growth Income Growth

MRQ Y/Y -0.85 %


MRQ Y/Y -22.24 %



NTRA

$112.66

$4.8500 4.50%
This Month of July


NTRA

$112.66

$4.8500 4.50%



Natera Inc

Natera Inc shares went up 4.50% during this month of July.


Natera Inc operates as a genetic testing company that provides non-invasive screening and diagnostic tests for reproductive health, oncology, and organ transplantation. The company*s business model is built around offering cost-effective and accurate genetic testing solutions for both patients and healthcare providers. Natera primarily generates revenue by selling its proprietary tests and associated analysis services to customers, including hospitals, laboratories, and physicians.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 13,610.905 mill. $ 1,208.556 mill. $ -365.463 mill. 121 mill. - Y/Y 52.11 %
Market Cap. Revenues TTM Net Income TTM

$ 13,610.905 mill.


$ 1,208.556 mill.


$ -365.463 mill.

Employees Shares Outstanding P/E

2,800


121 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 52.11 %


MRQ Y/Y - %



CDNA

$16.14

$0.7600 4.94%
This Month of July


CDNA

$16.14

$0.7600 4.94%



Caredx Inc

Caredx Inc shares went up 4.94% during this month of July.


Caredx Inc is a precision medicine company with a business model focused on transplant diagnostics. They develop and commercialize non-invasive tests to identify and monitor organ transplant rejection. By offering innovative solutions and services in the transplant field, Caredx Inc aims to improve outcomes for patients and provide healthcare professionals with valuable information to guide treatment decisions.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 834.315 mill. $ 275.111 mill. $ -183.194 mill. 52 mill. - Y/Y -6.75 %
Market Cap. Revenues TTM Net Income TTM

$ 834.315 mill.


$ 275.111 mill.


$ -183.194 mill.

Employees Shares Outstanding P/E

446


52 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -6.75 %


MRQ Y/Y - %



GEHC

$80.19

$3.9300 5.15%
This Month of July


GEHC

$80.19

$3.9300 5.15%



Ge Healthcare Technologies Inc

Ge Healthcare Technologies Inc stock increased 5.15% during this month of July.


GE Healthcare Technologies Inc*s business model is focused on providing innovative medical devices, healthcare information technology, and healthcare services to improve patient care and outcomes. The company offers a wide range of products and solutions in areas such as medical imaging, patient monitoring, diagnostics, and healthcare IT. They also collaborate with healthcare providers and partners to offer integrated solutions and support throughout the entire healthcare ecosystem.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 36,807.210 mill. $ 16,328.000 mill. $ 1,619.000 mill. 459 mill. 23.46 Y/Y -1.50 %
Market Cap. Revenues TTM Net Income TTM

$ 36,807.210 mill.


$ 16,328.000 mill.


$ 1,619.000 mill.

Employees Shares Outstanding P/E

-


459 mill.


23.46

Revenue Growth Income Growth

MRQ Y/Y -1.50 %


MRQ Y/Y 1.31 %



ENZ

$1.17

$0.0600 5.41%
This Month of July


ENZ

$1.17

$0.0600 5.41%



Enzo Biochem Inc

Enzo Biochem Inc shares went up 5.41% during this month of July.


Enzo Biochem Inc operates as a biotechnology company that specializes in the development and commercialization of innovative diagnostic and research products.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 59.690 mill. $ 32.466 mill. $ 32.566 mill. 51 mill. 0.00 Y/Y -47.65 %
Market Cap. Revenues TTM Net Income TTM

$ 59.690 mill.


$ 32.466 mill.


$ 32.566 mill.

Employees Shares Outstanding P/E

412


51 mill.


0.00

Revenue Growth Income Growth

MRQ Y/Y -47.65 %


MRQ Y/Y - %



DGX

$144.59

$7.5000 5.47%
This Month of July


DGX

$144.59

$7.5000 5.47%



Quest Diagnostics Inc

Quest Diagnostics Inc stock improved 5.47% during this month of July.


Quest Diagnostics Inc operates as a provider of clinical laboratory and diagnostic information services, serving patients, physicians, hospitals, and pharmaceutical companies. The company generates revenue by offering a range of diagnostic testing services, including laboratory analysis, test development, and specialized diagnostics.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 16,194.080 mill. $ 9,287.000 mill. $ 899.000 mill. 112 mill. 19.50 Y/Y 1.50 %
Market Cap. Revenues TTM Net Income TTM

$ 16,194.080 mill.


$ 9,287.000 mill.


$ 899.000 mill.

Employees Shares Outstanding P/E

49,000


112 mill.


19.50

Revenue Growth Income Growth

MRQ Y/Y 1.50 %


MRQ Y/Y -4.15 %



INCY

$64.25

$3.3800 5.55%
This Month of July


INCY

$64.25

$3.3800 5.55%



Incyte Corporation

Incyte Corporation shares increased 5.55% during this month of July.


Incyte Corporation is a biopharmaceutical company that focuses on the discovery, development, and commercialization of innovative medicines. Their business model revolves around extensive research and development efforts to identify potential drug candidates for various diseases. With a focus on oncology and other serious inflammatory conditions, Incyte aims to bring effective therapies to patients while collaborating with partners and leveraging their extensive intellectual property portfolio.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 14,598.821 mill. $ 3,767.865 mill. $ 745.444 mill. 227 mill. 19.52 Y/Y 8.93 %
Market Cap. Revenues TTM Net Income TTM

$ 14,598.821 mill.


$ 3,767.865 mill.


$ 745.444 mill.

Employees Shares Outstanding P/E

2,094


227 mill.


19.52

Revenue Growth Income Growth

MRQ Y/Y 8.93 %


MRQ Y/Y 681.22 %



VCYT

$22.59

$1.2600 5.91%
This Month of July


VCYT

$22.59

$1.2600 5.91%



Veracyte Inc

Veracyte Inc shares improved 5.91% during this month of July.


Veracyte Inc*s business model revolves around providing genomic diagnostic solutions to enable physicians to make more informed treatment decisions for patients.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 1,688.824 mill. $ 375.473 mill. $ -68.177 mill. 75 mill. - Y/Y 17.50 %
Market Cap. Revenues TTM Net Income TTM

$ 1,688.824 mill.


$ 375.473 mill.


$ -68.177 mill.

Employees Shares Outstanding P/E

677


75 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 17.50 %


MRQ Y/Y - %



FLGT

$21.26

$1.2200 6.09%
This Month of July


FLGT

$21.26

$1.2200 6.09%



Fulgent Genetics Inc

Fulgent Genetics Inc shares improved 6.09% during this month of July.


Fulgent Genetics Inc is a genetic testing company that offers comprehensive, flexible, and affordable genetic testing solutions for various applications, including clinical diagnostics, carrier screening, and genetic research.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 638.076 mill. $ 285.288 mill. $ -64.981 mill. 30 mill. - Y/Y -20.64 %
Market Cap. Revenues TTM Net Income TTM

$ 638.076 mill.


$ 285.288 mill.


$ -64.981 mill.

Employees Shares Outstanding P/E

284


30 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -20.64 %


MRQ Y/Y - %



CRL

$216.25

$13.0100 6.40%
This Month of July


CRL

$216.25

$13.0100 6.40%



Charles River Laboratories International inc

Charles River Laboratories International Inc shares went up 6.40% during this month of July.


Charles River Laboratories International Inc is a contract research organization (CRO) that provides essential services and support to the pharmaceutical, biotech, and medical device industries. They offer a wide range of research models, drug discovery and development services, safety assessments, and laboratory animal medicine to assist in the preclinical and clinical stages of drug development.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 11,210.833 mill. $ 4,111.596 mill. $ 450.898 mill. 52 mill. 25.43 Y/Y -1.73 %
Market Cap. Revenues TTM Net Income TTM

$ 11,210.833 mill.


$ 4,111.596 mill.


$ 450.898 mill.

Employees Shares Outstanding P/E

20,000


52 mill.


25.43

Revenue Growth Income Growth

MRQ Y/Y -1.73 %


MRQ Y/Y -28.35 %



RDNT

$62.69

$4.1400 7.07%
This Month of July


RDNT

$62.69

$4.1400 7.07%



Radnet Inc

Radnet Inc shares increased 7.07% during this month of July.


Radnet Inc is a medical diagnostic imaging company that operates a network of outpatient imaging centers. Their business model focuses on offering convenient and accessible imaging services to patients, partnering with healthcare providers, and leveraging technology to ensure efficient operations. By providing advanced diagnostic capabilities and collaborating with insurance companies, Radnet Inc aims to enhance patient care and streamline the imaging process.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 4,344.861 mill. $ 1,627.954 mill. $ 29.751 mill. 69 mill. - Y/Y 12.46 %
Market Cap. Revenues TTM Net Income TTM

$ 4,344.861 mill.


$ 1,627.954 mill.


$ 29.751 mill.

Employees Shares Outstanding P/E

8,700


69 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 12.46 %


MRQ Y/Y 8.92 %



ICLR

$340.86

$24.3500 7.69%
This Month of July


ICLR

$340.86

$24.3500 7.69%



Icon Plc

Icon Plc shares went up 7.69% during this month of July.


Icon Plc is a leading provider of clinical research services, specializing in the design and management of clinical trials for pharmaceutical and biotechnology companies. Their business model focuses on offering a comprehensive range of services, including study design, data management, regulatory support, and statistical analysis, to support the development of new drugs and medical devices. Icon Plc*s success lies in its ability to provide customized solutions to its clients, efficiently navigate the regulatory landscape, and consistently deliver high-quality and timely results.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 28,195.135 mill. $ 8,120.176 mill. $ 1,236.802 mill. 83 mill. 46.06 Y/Y 4.89 %
Market Cap. Revenues TTM Net Income TTM

$ 28,195.135 mill.


$ 8,120.176 mill.


$ 1,236.802 mill.

Employees Shares Outstanding P/E

15,950


83 mill.


46.06

Revenue Growth Income Growth

MRQ Y/Y 4.89 %


MRQ Y/Y 144.76 %



IQV

$225.89

$17.4000 8.35%
This Month of July


IQV

$225.89

$17.4000 8.35%



Iqvia Holdings Inc

Iqvia Holdings Inc shares improved 8.35% during this month of July.


IQVIA Holdings Inc is a multinational company that operates in the healthcare industry. Its business model revolves around providing advanced analytics, technology solutions, and clinical research services to help clients make informed decisions, optimize their operations, and accelerate drug development. By leveraging its vast data resources and expertise, IQVIA aims to support healthcare professionals in improving patient outcomes and driving innovation in the industry.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 41,631.527 mill. $ 15,069.000 mill. $ 1,357.000 mill. 184 mill. 30.71 Y/Y 2.33 %
Market Cap. Revenues TTM Net Income TTM

$ 41,631.527 mill.


$ 15,069.000 mill.


$ 1,357.000 mill.

Employees Shares Outstanding P/E

79,000


184 mill.


30.71

Revenue Growth Income Growth

MRQ Y/Y 2.33 %


MRQ Y/Y -0.35 %



MEDP

$444.48

$37.2400 9.14%
This Month of July


MEDP

$444.48

$37.2400 9.14%



Medpace Holdings Inc

Medpace Holdings Inc stock increased 9.14% during this month of July.


Medpace Holdings Inc is a contract research organization (CRO) that provides various services in the clinical research and development of drugs and medical devices.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 14,223.804 mill. $ 1,962.812 mill. $ 312.507 mill. 32 mill. 45.15 Y/Y 17.73 %
Market Cap. Revenues TTM Net Income TTM

$ 14,223.804 mill.


$ 1,962.812 mill.


$ 312.507 mill.

Employees Shares Outstanding P/E

3,900


32 mill.


45.15

Revenue Growth Income Growth

MRQ Y/Y 17.73 %


MRQ Y/Y 40.74 %



GNOM

$11.37

$0.9600 9.22%
This Month of July


GNOM

$11.37

$0.9600 9.22%



Complete Genomics Inc

Complete Genomics Inc shares improved 9.22% during this month of July.


Complete Genomics Inc operates in the field of genetic sequencing, offering end-to-end solutions for large-scale genomic research. They provide comprehensive DNA sequencing services, including sample preparation, sequencing, data analysis, and consulting, primarily catering to research institutions, pharmaceutical companies, and academic organizations.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 390.386 mill. $ 19.877 mill. $ -57.048 mill. 34 mill. - Y/Y -62.39 %
Market Cap. Revenues TTM Net Income TTM

$ 390.386 mill.


$ 19.877 mill.


$ -57.048 mill.

Employees Shares Outstanding P/E

-


34 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -62.39 %


MRQ Y/Y - %



XGN

$1.98

$0.1700 9.39%
This Month of July


XGN

$1.98

$0.1700 9.39%



Exagen Inc

Exagen Inc stock improved 9.39% during this month of July.


Exagen Inc*s business model revolves around providing diagnostic testing solutions in the field of autoimmune diseases.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 35.530 mill. $ 55.733 mill. $ 4.295 mill. 18 mill. - Y/Y 28.36 %
Market Cap. Revenues TTM Net Income TTM

$ 35.530 mill.


$ 55.733 mill.


$ 4.295 mill.

Employees Shares Outstanding P/E

-


18 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 28.36 %


MRQ Y/Y - %



EXAS

$47.05

$4.6200 10.89%
This Month of July


EXAS

$47.05

$4.6200 10.89%



Exact Sciences Corporation

Exact Sciences Corporation stock improved 10.89% during this month of July.


Exact Sciences Corporation is a medical diagnostics company that specializes in early cancer detection. Their business model involves developing and commercializing non-invasive, DNA-based tests for the detection of colorectal cancer, as well as other cancers and diseases. By leveraging advanced technology and partnerships with healthcare providers, Exact Sciences aims to improve patient outcomes through early detection and intervention.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 8,579.568 mill. $ 2,573.276 mill. $ -240.226 mill. 182 mill. - Y/Y 6.77 %
Market Cap. Revenues TTM Net Income TTM

$ 8,579.568 mill.


$ 2,573.276 mill.


$ -240.226 mill.

Employees Shares Outstanding P/E

5,361


182 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 6.77 %


MRQ Y/Y - %



VRDN

$14.69

$1.4800 11.20%
This Month of July


VRDN

$14.69

$1.4800 11.20%



Viridian Therapeutics Inc

Viridian Therapeutics Inc shares improved 11.20% during this month of July.


Viridian Therapeutics Inc is a biotechnology company that focuses on developing novel therapeutics to treat various diseases.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 897.545 mill. $ 0.288 mill. $ -218.125 mill. 61 mill. - Y/Y -26.53 %
Market Cap. Revenues TTM Net Income TTM

$ 897.545 mill.


$ 0.288 mill.


$ -218.125 mill.

Employees Shares Outstanding P/E

-


61 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -26.53 %


MRQ Y/Y - %



GH

$31.54

$3.2800 11.61%
This Month of July


GH

$31.54

$3.2800 11.61%



Guardant Health Inc

Guardant Health Inc stock went up 11.61% during this month of July.


Guardant Health Inc*s business model revolves around providing advanced genomic testing services for cancer patients. It specializes in developing liquid biopsy tests that analyze circulating tumor DNA (ctDNA) in the blood. These tests help in early cancer detection, treatment selection, and monitoring of cancer progression. Guardant Health Inc collaborates with healthcare providers, pharmaceutical companies, and researchers to provide these innovative tests and contribute to the advancement of precision medicine in oncology.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 3,838.796 mill. $ 603.725 mill. $ -460.901 mill. 122 mill. - Y/Y 30.90 %
Market Cap. Revenues TTM Net Income TTM

$ 3,838.796 mill.


$ 603.725 mill.


$ -460.901 mill.

Employees Shares Outstanding P/E

1,100


122 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 30.90 %


MRQ Y/Y - %



BDSX

$1.72

$0.1900 12.42%
This Month of July


BDSX

$1.72

$0.1900 12.42%



Biodesix Inc

Biodesix Inc shares increased 12.42% during this month of July.


Biodesix Inc is a biotechnology company that utilizes advanced diagnostics to develop personalized medicine solutions for improving patient outcomes. Their business model involves leveraging their proprietary blood-based tests and data analytics to assist healthcare providers in making informed treatment decisions. By partnering with pharmaceutical companies and healthcare institutions, Biodesix aims to commercialize their innovative solutions and drive adoption in the healthcare industry.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 137.099 mill. $ 44.026 mill. $ -63.345 mill. 80 mill. - Y/Y 21.46 %
Market Cap. Revenues TTM Net Income TTM

$ 137.099 mill.


$ 44.026 mill.


$ -63.345 mill.

Employees Shares Outstanding P/E

-


80 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 21.46 %


MRQ Y/Y - %



ONMD

$1.05

$0.1170 12.54%
This Month of July


ONMD

$1.05

$0.1170 12.54%



Onemednet Corporation

Onemednet Corporation stock went up 12.54% during this month of July.





Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 24.863 mill. $ 0.872 mill. $ -23.205 mill. 24 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 24.863 mill.


$ 0.872 mill.


$ -23.205 mill.

Employees Shares Outstanding P/E

-


24 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



BGLC

$0.53

$0.0600 12.77%
This Month of July


BGLC

$0.53

$0.0600 12.77%



Bionexus Gene Lab Corp

Bionexus Gene Lab Corp stock increased 12.77% during this month of July.


Bionexus Gene Lab Corp operates on a business model focused on genetic research and analysis. They provide services such as genetic testing, gene sequencing, and genetic counseling to individuals and institutions. By utilizing advanced technology and expertise, they aim to assist their clients in understanding genetic information for medical purposes and improved decision-making.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 9.364 mill. $ 9.775 mill. $ -2.664 mill. 18 mill. - Y/Y 0.20 %
Market Cap. Revenues TTM Net Income TTM

$ 9.364 mill.


$ 9.775 mill.


$ -2.664 mill.

Employees Shares Outstanding P/E

-


18 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 0.20 %


MRQ Y/Y - %



CELC

$18.79

$2.1500 12.92%
This Month of July


CELC

$18.79

$2.1500 12.92%



Celcuity Inc

Celcuity Inc shares improved 12.92% during this month of July.


Celcuity Inc is a biotechnology company that develops and commercializes diagnostic tests designed to classify patients* specific cancer subtypes. These tests help physicians select the most appropriate targeted therapies for their patients, ultimately improving treatment outcomes.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 631.570 mill. $ - mill. $ -74.498 mill. 34 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 631.570 mill.


$ - mill.


$ -74.498 mill.

Employees Shares Outstanding P/E

-


34 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



FTRE

$26.99

$3.1300 13.12%
This Month of July


FTRE

$26.99

$3.1300 13.12%



Fortrea Holdings Inc

Fortrea Holdings Inc shares improved 13.12% during this month of July.


Fortrea Holdings Inc is a company that operates through its subsidiaries in the business of software and technology services, providing innovative solutions and products to its clients. Its business model focuses on developing and delivering custom software applications, digital platforms, and consulting services to cater to the specific needs of various industries.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 2,412.381 mill. $ 3,771.100 mill. $ -104.400 mill. 89 mill. - Y/Y -78.70 %
Market Cap. Revenues TTM Net Income TTM

$ 2,412.381 mill.


$ 3,771.100 mill.


$ -104.400 mill.

Employees Shares Outstanding P/E

-


89 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -78.70 %


MRQ Y/Y - %



BIAF

$2.53

$0.3100 13.96%
This Month of July


BIAF

$2.53

$0.3100 13.96%



Bioaffinity Technologies Inc

Bioaffinity Technologies Inc stock increased 13.96% during this month of July.


Bioaffinity Technologies Inc is a biotechnology company specializing in developing and commercializing diagnostics for various medical conditions. They utilize their patented platform technology, Affinity?, which enables the detection of cancer and other diseases at an early stage through the use of biomarkers. The company focuses on licensing their technology and partnering with diagnostic companies, aiming to provide accurate, non-invasive, and cost-effective diagnostic solutions.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 25.086 mill. $ 4.938 mill. $ -8.366 mill. 10 mill. - Y/Y 261,180.24 %
Market Cap. Revenues TTM Net Income TTM

$ 25.086 mill.


$ 4.938 mill.


$ -8.366 mill.

Employees Shares Outstanding P/E

-


10 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 261,180.24 %


MRQ Y/Y - %



SERA

$7.04

$1.0000 16.56%
This Month of July


SERA

$7.04

$1.0000 16.56%



Sera Prognostics Inc

Sera Prognostics Inc stock increased 16.56% during this month of July.


Sera Prognostics Inc has a business model that focuses on developing and commercializing innovative diagnostic tests for predicting pregnancy complications.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 226.829 mill. $ - mill. $ -33.774 mill. 32 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 226.829 mill.


$ - mill.


$ -33.774 mill.

Employees Shares Outstanding P/E

-


32 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



MDXH

$2.7644

$0.4044 17.14%
This Month of July


MDXH

$2.7644

$0.4044 17.14%



Mdxhealth Sa

Mdxhealth Sa shares increased 17.14% during this month of July.


MDxHealth SA is a biotech company that primarily focuses on developing and commercializing molecular diagnostic tests to assist healthcare professionals in making informed treatment decisions for cancer patients. Their business model revolves around providing accurate and actionable diagnostic information to improve patient outcomes and potentially reduce healthcare costs.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 71.774 mill. $ 70.193 mill. $ -43.100 mill. 26 mill. - Y/Y 89.43 %
Market Cap. Revenues TTM Net Income TTM

$ 71.774 mill.


$ 70.193 mill.


$ -43.100 mill.

Employees Shares Outstanding P/E

-


26 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 89.43 %


MRQ Y/Y - %



OPGN

$3.06

$0.5570 22.25%
This Month of July


OPGN

$3.06

$0.5570 22.25%



Opgen Inc

Opgen Inc shares went up 22.25% during this month of July.


OpGen Inc*s business model revolves around providing molecular diagnostic solutions and informatics services to combat global healthcare challenges, particularly in the field of infectious diseases. They develop innovative technologies that assist healthcare professionals in identifying, treating, and preventing the spread of infectious pathogens.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 4.075 mill. $ 2.673 mill. $ -26.659 mill. 1 mill. - Y/Y -81.59 %
Market Cap. Revenues TTM Net Income TTM

$ 4.075 mill.


$ 2.673 mill.


$ -26.659 mill.

Employees Shares Outstanding P/E

-


1 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -81.59 %


MRQ Y/Y - %




 1 Day   Week  Current Month of July  30 Days 
Current Quarter Q3 of 2024  90 Days    Ytd    12 Months 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com